tracking
Indalo Targets Idiopathic Pulmonary Fibrosis

Indalo Targets Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis is a highly progressive and life threatening disease affects approximately 130,000 people in the United States.  It’s worse than many cancers.  According to the National Institute of Health, physicians are unsure of the cause, but the... Read more